Azithromycin for severe COVID-19

Lancet. 2020 Oct 3;396(10256):936-937. doi: 10.1016/S0140-6736(20)31863-8. Epub 2020 Sep 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Azithromycin*
  • Betacoronavirus
  • Brazil
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections* / drug therapy
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2
  • Standard of Care

Substances

  • Azithromycin